Background and Aims
Resistance to antibiotics and the capability to develop biofilm as two main virulent determinants of Klebsiella pneumoniae have important role in infection persistence. The aim of the study was to evaluate the association between the prevalence of aminoglycoside resistance and virulence genes and biofilm formation capacity in K. pneumoniae strains isolated from hospitalized patients in South‐West of Iran.
Methods
A total of 114 non‐duplicate clinical isolates of K. pneumoniae collected from Ahvaz teaching hospitals. Identification of species was performed by biochemical tests and then confirmed by polymerase chain reaction (PCR) of rpoB gene. The susceptibility to antibiotics was determined by Kirby−Bauer disk diffusion method. Biofilm formation was assessed by microtiter plate method. Finally, PCR was conducted to detect virulence gene determinants including fimbrial genes, aminoglycoside modifying enzymes‐ and 16S rRNA methylase (RMTase) genes.
Results
Totally, all collected strains were carbapenem resistant and showed multidrug‐ and extensively drug‐resistance phenotype (75% and 25%, respectively). Seventy‐one percent (n = 81) of isolates were non‐susceptible to aminoglycosides. Among aminoglycoside antibiotics, K. pneumoniae isolates showed the highest and lowest resistance rates to tobramycin (71%) and the amikacin (25%), respectively. All biofilm producer strains were positive for the presence virulence determinants including ecpA, fimA, mrkD, and mrkA. Of 81 aminoglycosides non‐susceptible isolates 33% were positive for the presence ant (2″)‐Ia as the most prevalent gene followed by aac (3′)‐IIa and armA (27%), aac (6′)‐Ib (18%), and aph (3′)‐Ia (15%).
Conclusion
K. pneumoniae isolates showed the highest and the lowest aminoglycoside resistance rates to tobramycin and amikacin, respectively. Majority of isolates were biofilm producers and there was significant association between antibiotic resistance pattern and the strength of biofilm production. The ant(2″)‐Ia, aac (3′)‐IIa, and armA genes in aminoglycoside‐resistant isolates.